Following President Joe Biden's recent announcement regarding the rescheduling of cannabis followed by Attorney General Merrick Garland's move to officially begin the process, many expected the task to then be delegated to the DEA, which is part of the Dept. of Justice (DOJ). That didn’t happen.
Garland’s decision to reclassify cannabis without the full backing of the DEA and its chief Anne Milgram has raised eyebrows and sparked debate and controversy, particularly within federal agencies.
Neither Milgram nor the DEA has provided an explanation for this omission, noted the Associated Press. The plan, revealed two months ago in a DOJ meeting, has unfolded exactly as discussed, despite the DEA’s reservations.
"DEA has not yet made a determination as to its views of the appropriate schedule for marijuana," reads a sentence found in Garland's 92-page proposed rules, released last Thursday.
However, DOJ attorneys overruled the DEA's request for more time, deeming the criteria “impermissibly narrow,” reported ...